Ann C. Duerr

9.7k citations

194 papers · 7.8k · 1 hit paper · h-index 48

Impact in

Virology top 0.2%
- HIV Research and Treatment
Microbiology top 0.5%
- Reproductive tract infections research

Papers in

Virology 52
- HIV Research and Treatment 52
Infectious Diseases 81
- HIV/AIDS Research and Interventions 74

Co-authors: Denise J. Jamieson (37 shared papers)Robert S. Klein (25 shared papers)Susan Buchbinder (6 shared papers)Lawrence Corey (7 shared papers)Paula C. Schuman (21 shared papers)Margaret. Juliana McElrath (11 shared papers)Susan Cu‐Uvin (24 shared papers)Javier R. Lama (36 shared papers)
Journals: The Journal of Infectious Diseases (14 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (14 papers)Obstetrics and Gynecology (10 papers)AIDS (9 papers)Clinical Infectious Diseases (9 papers)
Partner nations: United States Peru South Africa

In The Last Decade

Ann C. Duerr

186 papers receiving 7.4k citations

Ann C. Duerr's Hit Papers

align trajectories log scale

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial 2008 · 1.4k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2008 The Lancet

Peers

Countries citing papers authored by Ann C. Duerr

Since Specialization

Citations

This map shows the geographic impact of Ann C. Duerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann C. Duerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann C. Duerr more than expected).

Fields of papers citing papers by Ann C. Duerr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann C. Duerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann C. Duerr. The network helps show where Ann C. Duerr may publish in the future.

Co-authors

The 25 scholars most cited alongside Ann C. Duerr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann C. Duerr Line = papers co-authored together Ann C. Duerr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial The Lancet ·Susan Buchbinder, Devan V. Mehrotra, Ann C. Duerr, Daniel W. Fitzgerald, Robin Mogg, David Li, Peter B. Gilbert, Javier R. Lama Hit paper breakdown →	2008	1418
2	The outer boundary of the cytoskeleton: a lamina derived from plasma membrane proteins Cell ·Avri Ben‐Ze'ev, Ann C. Duerr, Frank Solomon, Sheldon Penman	1979	282
3	Prevalence, Incidence, and Type‐Specific Persistence of Human Papillomavirus in Human Immunodeficiency Virus (HIV)–Positive and HIV‐Negative Women The Journal of Infectious Diseases ·Linda Ahdieh, Robert S. Klein, Robert David Burk, Susan Cu‐Uvin, Paula C. Schuman, Ann C. Duerr, Mahboobeh Safaeian, Jacquie A. Astemborski	2001	270
4	Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand AIDS ·Craig R. Cohen, Ann C. Duerr, Niwat Pruithithada, Sungwal Rugpao, Patricia García, Kenrad E. Nelson, Sharon L. Hillier	1995	218
5	Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial Nature Medicine ·Morgane Rolland, Sodsai Tovanabutra, Allan C. deCamp, Nicole Frahm, Peter B. Gilbert, Eric Sanders‐Buell, Laura Heath, Craig A. Magaret	2011	197
6	Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women JNCI Journal of the National Cancer Institute ·Howard D. Strickler, Joel Michael Palefsky, K. V. Shah, K. Anastos, Robert S. Klein, HOWARD L. MINKOFF, Ann C. Duerr, Leslie Stewart Massad	2003	191
7	Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study) The Journal of Infectious Diseases ·Ann C. Duerr, Yunda Huang, Susan Buchbinder, Robert W. Coombs, Jorge Sánchez, Carlos del Rı́o, Martín Casapía, Solano Kaluangila Andrelino Santiago	2012	174
8	Merck Ad5/HIV induces broad innate immune activation that predicts CD8 + T-cell responses but is attenuated by preexisting Ad5 immunity Proceedings of the National Academy of Sciences ·Daniel E. Zak, Erica Andersen‐Nissen, Eric R. Peterson, Alicia Sato, M. Kristina Hamilton, Joleen A. Borgerding, Akshay T. Krishnamurty, Joanne T. Chang	2012	140
9	Male Viral Load and Heterosexual Transmission of HIV-1 Subtype E in Northern Thailand JAIDS Journal of Acquired Immune Deficiency Syndromes ·Sodsai Tovanabutra, Valerie A. Robison, Jeerang Wongtrakul, Supaluk Sennum, Vinai Suriyanon, Duangnapa Kingkeow, Surinda Kawichai, Praijitr Tanan	2002	134
10	Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine Current Opinion in HIV and AIDS ·Glenda Gray, Susan Buchbinder, Ann C. Duerr	2010	130
11	Longitudinal Study of Cervical Squamous Intraepithelial Lesions in Human Immunodeficiency Virus (HIV)–Seropositive and At‐Risk HIV‐Seronegative Women The Journal of Infectious Diseases ·Paula C. Schuman, Suzanne E. Ohmit, Robert S. Klein, Ann C. Duerr, Susan Cu‐Uvin, Denise J. Jamieson, Jean Anderson, Keerti V. Shah	2003	129
12	Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine Journal of Clinical Investigation ·Nicole Frahm, Allan C. deCamp, David P. Friedrich, Donald K. Carter, Olivier Defawe, James G. Kublin, Danilo R. Casimiro, Ann C. Duerr	2011	128
13	Changes in Sexual Behavior and STI Diagnoses Among MSM Initiating PrEP in a Clinic Setting AIDS and Behavior ·Michalina A. Montaño, Julia C. Dombrowski, Sayan Dasgupta, Matthew Robert Golden, Ann C. Duerr, Lisa E. Manhart, Lindley A. Barbee, Christine M. Khosropour	2018	117
14	Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic T cell clones Immunity ·Jack A. Collora, Runxia Liu, Delia Pinto-Santini, Neal G. Ravindra, Carmela Ganoza, Javier R. Lama, Ricardo Alfaro, Jennifer Chiarella	2022	103
15	Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation Vaccine ·Fusheng Li, Uma Malhotra, Peter B. Gilbert, Natalie R. Hawkins, Ann C. Duerr, Margaret. Juliana McElrath, Lawrence Corey, Steven G. Self	2006	95
16	HIV Vaccines: New Frontiers in Vaccine Development Clinical Infectious Diseases ·Ann C. Duerr, Judith N. Wasserheit, Lawrence Corey	2006	92
17	The Use of Nonhuman Primate Models in HIV Vaccine Development PLoS Medicine ·Cecilia A. Morgan, Marta L. Marthas, Christopher J. Miller, Ann C. Duerr, Cecilia Cheng‐Mayer, Ronald C. Desrosiers, Jorge Flores, Nancy Logan Haigwood	2008	87
18	Violence Among Women with or at Risk for HIV Infection AIDS and Behavior ·David Vlahov, Dina Wientge, Jan Moore, Colin P. Flynn, Paula C. Schuman, Ellie E. Schoenbaum, Sally Zierler, Anne M. Rompalo	1998	85
19	Mucosal Candidal Colonization and Candidiasis in Women with or at Risk for Human Immunodeficiency Virus Infection Clinical Infectious Diseases ·Paula C. Schuman, Jack D. Sobel, Suzanne E. Ohmit, Kenneth Hugh Mayer, Charles C. J. Carpenter, Anne M. Rompalo, Ann C. Duerr, Dawn K. Smith	1998	85
20	Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection American Journal of Obstetrics and Gynecology ·Denise J. Jamieson, Ann C. Duerr, Robert David Burk, Robert S. Klein, Pangaja Paramsothy, Paula C. Schuman, Susan Cu‐Uvin, Keerti V. Shah	2002	85

About Ann C. Duerr

Ann C. Duerr is a scholar working on Virology, Infectious Diseases, Microbiology, Epidemiology and General Health Professions, having authored 194 papers that have together received 7.8k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (74 papers), HIV Research and Treatment (52 papers), Reproductive tract infections research (27 papers), Adolescent Sexual and Reproductive Health (25 papers), HIV, Drug Use, Sexual Risk (23 papers), Cervical Cancer and HPV Research (19 papers), Sex work and related issues (14 papers) and Syphilis Diagnosis and Treatment (9 papers). The work is most often cited by research in Virology (2.2k citations), Microbiology (853 citations), Infectious Diseases (2.2k citations), Epidemiology (2.6k citations) and Immunology (1.3k citations). Ann C. Duerr has collaborated with scholars based in United States, Peru and South Africa. Frequent co-authors include Denise J. Jamieson, Robert S. Klein, Susan Buchbinder, Lawrence Corey, Paula C. Schuman, Margaret. Juliana McElrath, Susan Cu‐Uvin, Javier R. Lama, Peter B. Gilbert and Michael N. Robertson. Their work appears in journals such as The Journal of Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, Obstetrics and Gynecology, AIDS and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ann C. Duerr

Impact in

Papers in i

In The Last Decade

Ann C. Duerr

Ann C. Duerr's Hit Papers

Peers

Countries citing papers authored by Ann C. Duerr

Fields of papers citing papers by Ann C. Duerr

All Works

About Ann C. Duerr

Explore authors with similar magnitude of impact

Papers in